PainReform Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Net Income	-14.59	-9.34	-8.79	-7.25	-4.05	Upgrade
Depreciation & Amortization	0.02	0.02	0.02	0.01	-	Upgrade
Stock-Based Compensation	0.31	0.8	1.73	1.22	0.24	Upgrade
Other Operating Activities	-0.02	0.22	-0.09	-	2.13	Upgrade
Change in Accounts Payable	0.08	0.01	0.07	-0.59	0.72	Upgrade
Change in Other Net Operating Assets	1.58	1.62	0.6	0.05	-1.59	Upgrade
Operating Cash Flow	-12.62	-6.68	-6.46	-6.55	-2.56	Upgrade
Capital Expenditures	-0.01	-0.01	-0.01	-0.05	-0.01	Upgrade
Investment in Securities	-	6	-6	-	-	Upgrade
Investing Cash Flow	-0.01	5.99	-6.01	-0.05	-0.01	Upgrade
Issuance of Common Stock	10.1	4.21	-	7.93	17.31	Upgrade
Other Financing Activities	-1.24	0.4	-	-0.45	-	Upgrade
Financing Cash Flow	8.86	4.62	-	7.48	17.31	Upgrade
Foreign Exchange Rate Adjustments	0.01	0	-	-	-	Upgrade
Net Cash Flow	-3.77	3.93	-12.47	0.88	14.74	Upgrade
Free Cash Flow	-12.63	-6.69	-6.47	-6.6	-2.57	Upgrade
Free Cash Flow Per Share	-27.86	-122.63	-143.43	-158.54	-189.92	Upgrade
Levered Free Cash Flow	-7.52	-3.56	-3.12	-3.9	-2.76	Upgrade
Unlevered Free Cash Flow	-7.52	-3.56	-3.12	-3.9	-2.1	Upgrade
Change in Net Working Capital	-1.65	-1.62	-0.69	0.57	1.29	Upgrade

Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q